"/> Invitrogen™ Peptide synthétique ATG2B humain | B-LABO France

Invitrogen™ Peptide synthétique ATG2B humain

Réf. : BL-RE-176693Réf. fabricant : 15255379 50 μg
141,00 € HT

Synthetic Peptide

Gene ID (Entrez)
55102
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q96BY7
Nom usuel
Human ATG2B
Marque
Invitrogen

ATG2B Synthetic Peptide, PEP-1470, from Invitrogen.

Autophagy, the process of bulk degradation of cellular proteins through an autophagosomic-lysosomal pathway is important for normal growth control and may be defective in tumor cells. It is involved in the preservation of cellular nutrients under starvation conditions as well as the normal turnover of cytosolic components. This process is negatively regulated by TOR (Target of rapamycin) through phosphorylation of autophagy protein APG1. Another member of the autophagy family of proteins is ATG2B, one of two homologs of ATG2 that is essential for autophagosome formation and important for regulation of size and distribution of lipid droplets. Relatively high rates of ATG2B mutations were observed in gastric and colorectal carcinomas, suggesting that deregulating the autophagy process may contribute to cancer development.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-176693
Réf. fabricant15255379
Gene ID (Entrez)55102
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ96BY7
Nom usuelHuman ATG2B
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)ATG2B
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.